(Q56986486)

3

0 references

S. Jarius

4

0 references

T. Kümpfel

5

0 references

S. Schippling

6

0 references

B. Wildemann

7

0 references

C. Wilke

https://scigraph.springernature.com/pub.10.1007/s00115-010-3192-4

8

0 references

publication date

22 January 2011

0 references

published in

Der Nervenarzt

0 references

volume

82

0 references

issue

6

0 references

page(s)

768-777

0 references

exact match

0 references

cites work

Clinical practice. Optic neuritis

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Glatiramer acetate treatment in Devic's neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Two cases of benign neuromyelitis optica in patients with celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

A case of relapsing neuromyelitis optica treated with glatiramer acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

An open label study of the effects of rituximab in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Neuromyelitis optica in childhood: case report with sequential MRI findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

MR imaging of Devic's neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Relapsing neuromyelitis optica responsive to glatiramer acetate treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

An approach to the diagnosis of acute transverse myelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

NMO-IgG in the diagnosis of neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Chronic relapsing inflammatory optic neuropathy (CRION).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

NMO-IgG detected in CSF in seronegative neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Spectrum of pediatric neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Devic's neuromyelitis optica: a clinicopathological study of 8 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

NMO-IgG predicts the outcome of recurrent optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Intermittent plasmapheresis prevents recurrence in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Occurrence of acute large and edematous callosal lesions in neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Clinical, CSF, and MRI findings in Devic's neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Intermittent intravenous immunoglobulin successfully prevents relapses of neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Immunosuppressive therapy is more effective than interferon in neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

[Recent findings in pathogenesis, diagnostics and therapy of neuromyelitis optica].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Aquaporin-4 autoantibodies in a paraneoplastic context

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Brain abnormalities in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Hiccups, nausea, and vomiting: water channels under attack!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

EFNS guidelines on diagnosis and management of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

The clinical course of neuromyelitis optica (Devic's syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

The spectrum of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Revised diagnostic criteria for neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3192-4

Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis

21 January 2018

1 reference

12 December 2020

Devic's neuromyelitis optica treated with intravenous gamma globulin (IVIG).

1 reference

12 December 2020

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica

1 reference

12 December 2020

Immunoablative cyclophosphamide for refractory lupus-related neuromyelitis optica

1 reference

12 December 2020

Neuromyelitis optica in the elderly

1 reference

12 December 2020

[Neuromyelitis optica]

1 reference

12 December 2020

1 reference

12 December 2020

Neuromyelitis and more: the unfolding spectrum of aquaporin 4-related neurological diseases

1 reference

12 December 2020

Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients

1 reference

12 December 2020

Devic's neuromyelitis optica during pregnancy in a patient with systemic lupus erythematosus

1 reference

12 December 2020

Supraspinal demyelinating lesions in neuromyelitis optica display a typical astrocyte pathology.

1 reference

12 December 2020

Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study

1 reference

12 December 2020

Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjögren's syndrome

1 reference

12 December 2020

Interferon-beta(1b) treatment in neuromyelitis optica

1 reference

12 December 2020

Relapsing demyelinating CNS disease in a Korean pediatric population: multiple sclerosis versus neuromyelitis optica

1 reference

12 December 2020

MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT

1 reference

12 December 2020

Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis

1 reference

12 December 2020

Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine

1 reference

12 December 2020

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4

1 reference

12 December 2020

Neuromyelitis optica and non organ-specific autoimmunity

1 reference

12 December 2020

Causes and early diagnosis of vitamin B12 deficiency

1 reference

12 December 2020

Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica

1 reference

12 December 2020

Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis

1 reference

12 December 2020